Business Description
![Q BioMed Inc Q BioMed Inc logo](https://static.gurufocus.com/logos/0C0000ARSY.png?12)
Q BioMed Inc
NAICS : 325412
SIC : 2834
ISIN : US74736N1054
Description
Q BioMed Inc is a biomedical acceleration and development company. It has a focus on licensing, acquiring, and providing strategic resources to life sciences and healthcare companies. The company intends to mitigate risk by acquiring multiple assets over time and across a broad spectrum of healthcare-related products, companies, and sectors. Generic Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. It also has three development-stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder, Uttroside-B for liver cancer, and MAN 01 for glaucoma.
Financial Strength
Name | Current | Vs Industry | Vs History |
---|
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 44.14 | |||||
9-Day RSI | 40.71 | |||||
14-Day RSI | 40.55 | |||||
6-1 Month Momentum % | -70 | |||||
12-1 Month Momentum % | -97.83 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
FCF Margin % | 1043.54 |
GF Value Rank
Name | Current | Vs Industry | Vs History |
---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:QBIO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Q BioMed Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 0.209 | ||
EPS (TTM) ($) | -0.084 | ||
Beta | 157.36 | ||
Volatility % | 284.15 | ||
14-Day RSI | 40.55 | ||
14-Day ATR ($) | 0.00002 | ||
20-Day SMA ($) | 0.000245 | ||
12-1 Month Momentum % | -97.83 | ||
52-Week Range ($) | 0.0001 - 0.0155 | ||
Shares Outstanding (Mil) | 145.09 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 0 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Q BioMed Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Q BioMed Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Q BioMed Inc Frequently Asked Questions
What is Q BioMed Inc(QBIO)'s stock price today?
The current price of QBIO is $0.00. The 52 week high of QBIO is $0.02 and 52 week low is $0.00.
When is next earnings date of Q BioMed Inc(QBIO)?
The next earnings date of Q BioMed Inc(QBIO) is .
Does Q BioMed Inc(QBIO) pay dividends? If so, how much?
Q BioMed Inc(QBIO) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |